Patients should be closely monitored for any adverse reactions, and dosages may be adjusted depending on individual response and tolerance
GLP-1 for Type 2 Diabetes: Beyond Blood Sugar Control When GLP-1 medications first emerged for Type 2 diabetes, they were one option among many for lowering blood sugar
Abstract Cardiovascular outcome trials of the incretin-based medicines tirzepatide and semaglutide have shown benefits in populations with varying levels of cardiovascular risk
Both medications carry a boxed warning about thyroid C-cell tumors observed in rodent studies (though not confirmed in humans) and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
If injection-site reactions are persistent enough to disrupt your routine, tell your provider, who may suggest additional precautions or a different administration approach for your situation
when immune function is compromised it can lead to inflammation and skin conditions, including acne and eczema